FDA tells doctors to use heartburn drug as last resortBMJ 2000; 320 doi: https://doi.org/10.1136/bmj.320.7231.336/i (Published 05 February 2000) Cite this as: BMJ 2000;320:336
- Scott Gottlieb
- New York
The Food and Drug Administration has issued a stern warning that the popular heartburn drug cisapride can cause dangerous irregular heart beats and even sudden death and should be used only as a last resort in patients with the worst cases of gastro-oesophageal reflux disease when other treatments have failed.
Patients now taking cisapride should ask their doctors about switching treatment, and doctors should not prescribe the drug without first performing electrocardiography to rule out underlying cardiac abnormalities, according to the warning. The drug's trade name is Propulsid in the United States and Prepulsid in the United Kingdom.
The administration also included in the warning some new contraindicated drugs, such …
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.